Eric Kenneth Olson
Salt Lake City, UT — (April 12, 2016) – Predictive Technology Group, Inc. (OTC PINK: PRED), announces that the Company has completed its acquisition of ReNovo Biotech, Inc., and has established a new wholly-owned subsidiary called Predictive Biotech, Inc.
The acquisition provides PRED access to ReNovo Biotech’s cellular, tissue, biomaterial and regenerative medicine products and product candidates. Also, PRED will gain access to ReNovo’s distribution channels, including access to customers from the recent signing of several private label agreements.
As part of PRED’s acquisition and restructuring, ReNovo Biotech’s CEO Eric Olson has been appointed as the President of Predictive Biotech, Inc.
